Ocular Therapeutix, Inc. (OCUL)
7.78
+0.75
(+10.67%)
USD |
NASDAQ |
Feb 20, 16:00
7.68
-0.10
(-1.29%)
After-Hours: 20:00
Ocular Therapeutix SG&A Expense (Quarterly) : 30.62M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Boston Scientific Corp. | 1.834B |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| EyePoint Plc | 14.52M |
| Vertex Pharmaceuticals, Inc. | 487.00M |